NIH

A new study finds that uninsured heart attack patients are more likely to be transferred. Read More

New findings identify isoketal-modified proteins as a previously unrecognized feature of pulmonary fibrosis and as a potential therapeutic target for this disease. Read More

Vanderbilt researchers have identified biomarkers that could be useful for evaluating and treating pregnancy-related heart failure. Read More

A research team at Vanderbilt University Medical Center (VUMC) will develop a crowdsourcing solution for generating a wide range of labeled data sets from electronic health records (EHRs). Read More

Researchers at Vanderbilt University Medical Center (VUMC), the University of Miami and Meharry Medical College were recently awarded a five-year, $11.6 million grant to launch a new center that will enable research using precision medicine to eradicate health disparities, specifically those among African-Americans and Latinos. Read More

Researchers at Vanderbilt University School of Medicine have received a four-year, $4 million grant from the National Institutes of Health (NIH) to establish a new center for the study of privacy concerns associated with the use of genomic information, the NIH announced this week. Read More

Collybolide – a natural product isolated from a mushroom – is a promising candidate for the development of non-addictive pain medicines. Read More

COX-2 inhibitors – used clinically to reduce inflammation and pain – may find new applications for treating PTSD and other stress-related psychiatric disorders like major depression. Read More

A newly discovered mechanism that helps cancer cells avoid destruction by immune system cells may improve immunotherapies. Read More

A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.” Read More